Research ArticleArticle
Serum Pyridinoline Levels and Prediction of Severity of Joint Destruction in Rheumatoid Arthritis
Annemarie Krabben, Rachel Knevel, Tom W.J. Huizinga, Guy Cavet and Annette H.M. van der Helm-van Mil
The Journal of Rheumatology June 2013, jrheum.121392; DOI: https://doi.org/10.3899/jrheum.121392
Annemarie Krabben
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; and Crescendo Bioscience Inc., South San Francisco, California, USA. A. Krabben was supported by a grant from the Dutch Arthritis Foundation. A.H.M. van der Helm-van Mil was supported by a grant from the Dutch Organization of Health Research and Development. Research was supported by The European Community Seventh Framework Program FP7 Health-F2-2008-223404 (Masterswitch) and by a core grant from the Dutch Arthritis Foundation. A. Krabben, MSc, MD; R. Knevel, MD; T.W.J. Huizinga, MD, PhD, Department of Rheumatology, Leiden University Medical Center; G. Cavet, PhD, Crescendo Bioscience Inc.; A.H.M. van der Helm-van Mil, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. A. Krabben, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. E-mail: A.Krabben@lumc.nl. Accepted for publication March 28, 2013.
Rachel Knevel
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; and Crescendo Bioscience Inc., South San Francisco, California, USA. A. Krabben was supported by a grant from the Dutch Arthritis Foundation. A.H.M. van der Helm-van Mil was supported by a grant from the Dutch Organization of Health Research and Development. Research was supported by The European Community Seventh Framework Program FP7 Health-F2-2008-223404 (Masterswitch) and by a core grant from the Dutch Arthritis Foundation. A. Krabben, MSc, MD; R. Knevel, MD; T.W.J. Huizinga, MD, PhD, Department of Rheumatology, Leiden University Medical Center; G. Cavet, PhD, Crescendo Bioscience Inc.; A.H.M. van der Helm-van Mil, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. A. Krabben, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. E-mail: A.Krabben@lumc.nl. Accepted for publication March 28, 2013.
Tom W.J. Huizinga
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; and Crescendo Bioscience Inc., South San Francisco, California, USA. A. Krabben was supported by a grant from the Dutch Arthritis Foundation. A.H.M. van der Helm-van Mil was supported by a grant from the Dutch Organization of Health Research and Development. Research was supported by The European Community Seventh Framework Program FP7 Health-F2-2008-223404 (Masterswitch) and by a core grant from the Dutch Arthritis Foundation. A. Krabben, MSc, MD; R. Knevel, MD; T.W.J. Huizinga, MD, PhD, Department of Rheumatology, Leiden University Medical Center; G. Cavet, PhD, Crescendo Bioscience Inc.; A.H.M. van der Helm-van Mil, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. A. Krabben, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. E-mail: A.Krabben@lumc.nl. Accepted for publication March 28, 2013.
Guy Cavet
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; and Crescendo Bioscience Inc., South San Francisco, California, USA. A. Krabben was supported by a grant from the Dutch Arthritis Foundation. A.H.M. van der Helm-van Mil was supported by a grant from the Dutch Organization of Health Research and Development. Research was supported by The European Community Seventh Framework Program FP7 Health-F2-2008-223404 (Masterswitch) and by a core grant from the Dutch Arthritis Foundation. A. Krabben, MSc, MD; R. Knevel, MD; T.W.J. Huizinga, MD, PhD, Department of Rheumatology, Leiden University Medical Center; G. Cavet, PhD, Crescendo Bioscience Inc.; A.H.M. van der Helm-van Mil, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. A. Krabben, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. E-mail: A.Krabben@lumc.nl. Accepted for publication March 28, 2013.
Annette H.M. van der Helm-van Mil
From the Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands; and Crescendo Bioscience Inc., South San Francisco, California, USA. A. Krabben was supported by a grant from the Dutch Arthritis Foundation. A.H.M. van der Helm-van Mil was supported by a grant from the Dutch Organization of Health Research and Development. Research was supported by The European Community Seventh Framework Program FP7 Health-F2-2008-223404 (Masterswitch) and by a core grant from the Dutch Arthritis Foundation. A. Krabben, MSc, MD; R. Knevel, MD; T.W.J. Huizinga, MD, PhD, Department of Rheumatology, Leiden University Medical Center; G. Cavet, PhD, Crescendo Bioscience Inc.; A.H.M. van der Helm-van Mil, MD, PhD, Department of Rheumatology, Leiden University Medical Center. Address correspondence to Dr. A. Krabben, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands. E-mail: A.Krabben@lumc.nl. Accepted for publication March 28, 2013.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Serum Pyridinoline Levels and Prediction of Severity of Joint Destruction in Rheumatoid Arthritis
Annemarie Krabben, Rachel Knevel, Tom W.J. Huizinga, Guy Cavet, Annette H.M. van der Helm-van Mil
The Journal of Rheumatology Jun 2013, jrheum.121392; DOI: 10.3899/jrheum.121392